Antiemetics Market
Global Antiemetics Market Size, Share & Trends Analysis Report by Drug Class (5-HT3 receptor antagonists, Anticholinergics, Benzodiazepines, Cannabinoids, and Others), and by Application (Chemotherapy, Gastroenteritis, General Anaesthetics, Pregnancy, and Others) Forecast 2022-2028 Update Available - Forecast 2024-2030
The global antiemetics market is anticipated to grow at a significant CAGR during the forecast period. Antiemetics is a therapeutic drug that preventsmedical sickness such as nausea and vomiting. It is used to treat the aforementioned condition caused by a range of illnesses. Antiemetics are commonly used to treat and its side effect of opioid analgesics, general anesthetics, and chemotherapy. Thus, the antiemetics market is anticipated to grow owing to the rising prevalence of chronic diseases such as cancer, and others. As per the data released by the World Health Organization, around 10 million mortalities occurred due to the lack of medical treatment.
Vomiting and nausea are consequences faced by patients suffering from illnesses such as motion sickness, dizziness, and food poisoning. In addition, gastroenteritis, if the patients are dehydrated antiemetics is used. Antiemetics drug is very helpful for women.These drugs provide remarkable relief to the women who undergo morning sickness in the early phase of the pregnancy. Lack of awareness regarding the vailability of variety of antiemetic among the medical practitioners restrains the growth of the global market. Despite the presence of a range of drugs, the practitioners prescribe the similar drugs to treat patients with different conditions of nausea. Morever, prominence of only a few drugs leads to lower the demand of other drugs and thus restricts the overall growth of this market. For instance, the American Society of Clinical Oncology released its first guideline in the 'Choosing Wisely' (CW) campaign to prevent and discourage the overuse of expensive and similar kind of antiemetic drugs for all ailments.
Impact of COVID-19 on Global Antiemetics Market
The COVID-19 pandemic has made negative impact on the growth of the global antiemetics market. Supply chain disruptions, temporary halt of production process, and reduction in demand for these drugs due to reduction in chemotherapy procedures during the COVID-19 pandemic are the key factor driving the growth of the global antiemetic market. However, the market is anticipated to exhibit V-share recovery during the forecast period.
Segmental Outlook
The global antiemetics market is segmented based on the drug class and application. Based on the drug class, the market is segmented into 5-HT3 receptor antagonists, anticholinergics, benzodiazepines, cannabinoids, others. Based on the application, the market is sub-segmented into chemotherapy, gastroenteritis, general anaesthetics, pregnancy, and others. The above-mentioned segments can be customized as per the requirements.
Global Antiemetics Market Share by Applicatiom, 2021(%)
The Chemotherapy Segment is Anticipated to Hold a Prominent Share in the Global Antiemetics Market
Based on the application, the market is sub-segmented into chemotherapy, gastroenteritis, general anaesthetics, pregnancy, and others. The above-mentioned segments can be customized as per the requirements. Among these, chemotherapy held the largest share among all the applications of the antiemetic drugs. It is the standard treatment used to deal with cancer. It is accompanied by the side effect of nausea and vomiting. The rising incidences of cancer casesaross the globe has created demand for antiemetic drugs. Chemotherapy is used for the treatment of cancer side effects like vomiting and nausea. IT is in turn support the usage of antiemetic drugs.
Regional Outlooks
The global antiemetic market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East &Africa, and Latin America). The market can be analyzed for a particular regionlevel as per the requirement.
Global Antiemetics Market Growth, by Region 2021-2028
North America Held the Major Share in the Global Antiemetics Market
North America held largest share in the global antiemetics market. The presence of key market players, high awareness among people regarding these drugs, and high incidence rate of cancer patients among others are the key factors driving the growth of the regional market. However, Asia-Pacific is anticipated to exhibit significant growth in antiemetics market during the forecast period.
Market Players Outlook
The major companies serving the global antiemetics market include GlaxoSmithKline plc, Merck KGaA, Eli Lilly and Co., Pfizer Inc,and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new launches, to stay competitive in the market.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the Global AntiemeticsMarket. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of marketentry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on heGlobal Antiemetics Market
• Recovery Scenario of Global Antiemetics Market
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. BY Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. AstellasPharma Inc.
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. Eli Lilly and Co.
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. GlaxoSmithKline plc
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. Merck KGaA
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. Key Strategy Analysis
3.6. Impact of Covid-19 on Key Players
4. Market Segmentation
4.1. Global Antiemetics Market by Drug Class
4.1.1. 5-HT3 receptor antagonists
4.1.2. Anticholinergics
4.1.3. Benzodiazepines
4.1.4. Cannabinoids
4.1.5. Others
4.2. Global Antiemetics Market by Application
4.2.1. Chemotherapy
4.2.2. Gastroenteritis
4.2.3. General anesthetics
4.2.4. Pregnancy
4.2.5. Others
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. AbbottLaboratories
6.2. BaxterInternational Inc.
6.3. Bristol Myers Squibb
6.4. Cipla Ltd.
6.5. IPCA Labs
6.6. Johnson & Johnson
6.7. Novartis AG
6.8. Pfizer
6.9. Reddy Laboratories Ltd.
6.10. Sanofi SA
1. GLOBAL ANTIEMETICS MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2021-2028 ($ MILLION)
2. GLOBAL 5-HT3 RECEPTOR ANTAGONISTS ANTIEMETICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL ANTICHOLINERGICS ANTIEMETICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4. GLOBAL BENZODIAZEPINES ANTIEMETICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
5. GLOBAL CANNABINOIDS ANTIEMETICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
6. GLOBAL STEROIDS ANTIEMETICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
7. GLOBAL ANTIEMETICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
8. GLOBALCHEMOTHERAPY ANTIEMETICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
9. GLOBAL GASTROENTERITIS ANTIEMETICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
10. GLOBAL GENERAL ANAESTHETICS ANTIEMETICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
11. GLOBAL PREGNANCY ANTIEMETICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
12. GLOBAL FOOD POISONING ANTIEMETICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
13. GLOBALANTIEMETICS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
14. NORTH AMERICAN ANTIEMETICSMARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
15. NORTH AMERICAN ANTIEMETICSMARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2021-2028 ($ MILLION)
16. NORTH AMERICAN ANTIEMETICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
17. EUROPEAN ANTIEMETICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
18. EUROPEAN ANTIEMETICS MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2021-2028 ($ MILLION)
19. EUROPEAN ANTIEMETICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
20. ASIA-PACIFIC ANTIEMETICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
21. ASIA-PACIFIC ANTIEMETICS MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2021-2028 ($ MILLION)
22. ASIA-PACIFIC ANTIEMETICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
23. REST OF THE WORLD ANTIEMETICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
24. REST OF THE WORLD ANTIEMETICS MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2021-2028 ($ MILLION)
25. REST OF THE WORLD ANTIEMETICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
1. IMPACT OF COVID-19 ON GLOBAL ANTIEMETICS MARKET, 2021-2028 ($ MILLION)
2. IMPACT OF COVID-19 ON GLOBAL ANTIEMETICS MARKET BY SEGMENT, 2021-2028 ($ MILLION)
3. RECOVERY OF GLOBAL ANTIEMETICS MARKET, 2021-2028 (%)
4. GLOBAL ANTIEMETICS MARKET SHARE BY DRUG CLASS, 2021 VS 2028 (%)
5. GLOBAL 5-HT3 RECEPTOR ANTAGONISTS ANTIEMETICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
6. GLOBAL ANTICHOLINERGICS ANTIEMETICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
7. GLOBAL BENZODIAZEPINES ANTIEMETICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
8. GLOBAL CANNABINOIDS ANTIEMETICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
9. GLOBAL STEROIDS ANTIEMETICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
10. GLOBAL ANTIEMETICS MARKET SHARE BY APPLICATION, 2021 VS 2028 (%)
11. GLOBAL CHEMOTHERAPY ANTIEMETICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
12. GLOBAL GASTROENTERITIS ANTIEMETICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
13. GLOBAL GENERAL ANAESTHETICS ANTIEMETICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
14. GLOBAL PREGNANCY ANTIEMETICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
15. GLOBAL FOOD POISONING ANTIEMETICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
16. GLOBAL ANTIEMETICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
17. US ANTIEMETICS MARKET SIZE, 2021-2028 ($ MILLION)
18. CANADA ANTIEMETICS MARKET SIZE, 2021-2028 ($ MILLION)
19. UK ANTIEMETICS MARKET SIZE, 2021-2028 ($ MILLION)
20. FRANCE ANTIEMETICS MARKET SIZE, 2021-2028 ($ MILLION)
21. GERMANY ANTIEMETICS MARKET SIZE, 2021-2028 ($ MILLION)
22. ITALY ANTIEMETICS MARKET SIZE, 2021-2028 ($ MILLION)
23. SPAIN ANTIEMETICS MARKET SIZE, 2021-2028 ($ MILLION)
24. REST OF EUROPE ANTIEMETICS MARKET SIZE, 2021-2028 ($ MILLION)
25. INDIA ANTIEMETICS MARKET SIZE, 2021-2028 ($ MILLION)
26. CHINA ANTIEMETICS MARKET SIZE, 2021-2028 ($ MILLION)
27. JAPAN ANTIEMETICS MARKET SIZE, 2021-2028 ($ MILLION)
28. SOUTH KOREA ANTIEMETICS MARKET SIZE, 2021-2028 ($ MILLION)
29. REST OF ASIA-PACIFIC ANTIEMETICS MARKET SIZE, 2021-2028 ($ MILLION)
30. REST OF THE WORLD ANTIEMETICS MARKET SIZE, 2021-2028 ($ MILLION)
